Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

BACKGROUND: In patients with acute coronary syndrome (ACS), angiotensin-converting enzyme (ACE) inhibitors are preferred over angiotensin receptor blockers (ARBs). However, in a recent pilot study, treatment with ACE inhibitors was associated with increased platelet reactivity compared to ARBs. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Tscharre, Maximilian, Wadowski, Patricia P., Weikert, Constantin, Pultar, Joseph, Eichelberger, Beate, Panzer, Simon, Gremmel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578055/
https://www.ncbi.nlm.nih.gov/pubmed/33337519
http://dx.doi.org/10.1007/s10557-020-07128-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578055/
https://www.ncbi.nlm.nih.gov/pubmed/33337519
http://dx.doi.org/10.1007/s10557-020-07128-0

Ejemplares similares